Recent research has focused on the potential therapeutic use of CD70 in cancer treatment. One strategy being investigated is the use of antibodies that target CD70. ARGX-110 is a CD70-specific antibody that is currently under investigation for the treatment of hematological malignancies.
Recent studies have focused on the use of CD70 in cancer therapy. One method under investigation includes antibodies that target CD70. ARGX-110, a CD70-specific antibody, is currently being studied for treating hematological cancers.